Inspra (Eplerenone)

Inspra (Eplerenone): Comprehensive Patient Information for Australia

Basic Product Information

• International Nonproprietary Name (INN): Eplerenone
• Australia Brand Names: Inspra
• Anatomical Therapeutic Chemical (ATC) Code: C03DA04
• Available Forms and Strengths: Film-coated tablets in 25 mg and 50 mg strengths
• Manufacturers: Pfizer Australia Pty Ltd
• Prescription Status: Prescription only medicine (Schedule 4 – S4)

Mechanism of Action

For Patients: Eplerenone works by blocking the action of a hormone called aldosterone in your body. Aldosterone controls the salt and water balance. By blocking this hormone, Eplerenone helps remove extra salt and water from your body, while keeping potassium levels steady. This helps lower blood pressure and eases the workload on your heart.

For Healthcare Professionals: Eplerenone is a selective aldosterone receptor antagonist (SARA), reducing blood pressure and improving cardiovascular outcomes by inhibiting aldosterone-induced sodium reabsorption and potassium excretion in the distal renal tubules. It offers a more favourable side effect profile compared to spironolactone, notably less anti-androgenic and progesterone receptor cross-reactivity.

Pharmacokinetics

• Absorption: Oral bioavailability is approximately 69%. Peak plasma concentration occurs within 1.5 to 2 hours after ingestion.
• Metabolism: Extensively metabolised by the liver (mainly CYP3A4 enzyme), producing inactive metabolites.
• Elimination: Mostly excreted via the urine (67%) and faeces (32%). Elimination half-life is about 3–6 hours.
• Duration of action: Once-daily dosing is generally effective due to sufficient pharmacodynamic effect.

Use in Everyday Life and Best Practices (Australia Context)

Eplerenone is most commonly used by adults with heart failure (especially after a heart attack) and to treat high blood pressure that persists despite other medications. It may also be used in chronic heart failure (with reduced ejection fraction) and in other selected conditions where reducing fluid overload is important.

• Always take Eplerenone exactly as prescribed by your doctor or pharmacist.
• The typical starting dose is 25 mg once daily, which may increase to 50 mg once daily after two weeks depending on your response and blood test results.
• Tablets should be swallowed whole with a glass of water. Do not crush or chew.
• Consistent daily use is important for full benefit. Missing doses can reduce effectiveness.
• Regular blood tests (for potassium and kidney function) are essential, especially in the first weeks of therapy.
• Discuss all your current medications with your pharmacist or GP to avoid interactions.

Dosing in the Morning vs Evening

Advantages of Morning Dosing: Taking Eplerenone in the morning aligns with the body’s natural rhythm of salt and water management and is typically convenient for daily routines, reducing the chances of missed doses. Some evidence suggests this may lower the risk of nocturia (frequent urination at night).

Evening Dosing: May be preferred if you experience drowsiness or gastrointestinal discomfort. Discuss with your healthcare provider if you have shift work or variable daily schedules.

• Choose a time you can stick to daily.
• If you miss your morning dose, take it as soon as possible, unless it is almost time for the next dose.

Taking with Food or on an Empty Stomach

Eplerenone may be taken with or without food. Food does not significantly affect absorption. In the Australian diet, no special precautions are needed, but always follow your healthcare team's advice about salt and potassium intake. Avoid large amounts of high-potassium foods (e.g., bananas, oranges, tomatoes) unless instructed otherwise.

• For those with sensitive stomachs, taking with food may reduce mild nausea.
• Stay well hydrated, especially during hot Australia summers or after physical activity.

Interaction Warnings

Indications

Dosing According to Clinical Indication

Safety Profile and Side Effects

• Common Side Effects:
  • High potassium (hyperkalaemia)
  • Dizziness or light-headedness (may lead to fainting, especially when standing suddenly)
  • Diarrhoea or stomach upset
  • Fatigue or weakness
• Uncommon but Serious Side Effects:
  • Severe hyperkalaemia (can lead to abnormal heart rhythm)
  • Kidney impairment
  • Allergic reactions (rash, swelling, difficulty breathing; rare)
• Warnings:
  • People with severe kidney problems or diabetes with microalbuminuria should not use Eplerenone without specialist oversight.
  • Periodic blood tests are crucial for safe use, especially in elderly or those taking other potassium-raising medicines.

Guidelines for Proper Use (Australia Context)

• Keep regular medical and laboratory appointments.
• Store tablets below 25°C, away from direct sunlight and moisture—typical for Australian homes.
• If travelling, carry medication in original packaging with prescription labels.
• Consult your doctor before stopping treatment—sudden discontinuation may worsen your condition.
• If you experience muscle weakness, heartbeat changes, or severe dizziness, seek medical attention promptly.
• Inform pharmacists of all your current medicines, including over-the-counter or herbal products.
• Australian summers: Stay hydrated, but do not overdrink water unless told otherwise due to blood sodium or potassium monitoring.

Alternative Treatment Options (PBS-Listed Comparable Medicines)

• Spironolactone
  • Similar class; more anti-androgenic side effects (gynecomastia, menstrual disturbances)
  • Less expensive and more widely used for resistant hypertension and heart failure
• Amiloride
  • Potassium-sparing diuretic, less potent for heart failure indications
  • Mainly adjunct for hypertension
• Thiazide Diuretics (e.g., hydrochlorothiazide)
  • Promote sodium/water loss but may increase potassium loss
  • First-line for uncomplicated hypertension in some patients
• Comparative Overview: Eplerenone is preferred when less hormonal side effects are desired and in specific post-heart attack heart failure patients. Spironolactone is more commonly reimbursed but has a higher side effect risk, particularly in men.

Legal, Registration, and Reimbursement Status in Australia

• Therapeutic Goods Administration (TGA): Eplerenone (Inspra) is TGA registered for use in heart failure and left ventricular dysfunction post-MI.
• Pharmaceutical Benefits Scheme (PBS): Reimbursed for TGA-approved indications; restrictions may apply. Your GP, specialist or pharmacist can advise according to the latest PBS schedule.
• Prescription Requirements: Only available with a valid medical prescription. Repeat supply (script repeats) is possible for chronic use.
• National supply: Readily available through Australian community pharmacies and hospital pharmacies.
• Authority Script: May be required for specific clinical scenarios; consult your prescriber.

Latest Research and Clinical Guidance (2022–2025)

• Australian and international studies (e.g., 2022 ESC/ESH and 2023 Heart Foundation guidelines) confirm Eplerenone's benefits in reducing cardiovascular events for heart failure with reduced ejection fraction, as well as added safety over spironolactone in patients sensitive to hormonal side effects.
  Reference: McDonagh TA, et al. "2022 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure." Eur Heart J 2022.
• Latest meta-analyses place Eplerenone as an important agent for patients intolerant to spironolactone.
  Reference: Australian Heart Foundation "Heart failure: diagnosis and management" 2022–2023 Update.
• New pharmacovigilance data as of 2024 show no emerging safety issues in the Australian population when used as directed.

Availability and Delivery

Frequently Asked Questions (FAQ)

• Should I take Inspra in the morning or evening?
  Taking it in the morning is most common and practical, but the important thing is to take it at the same time each day as recommended by your doctor.
• Can I eat bananas or foods high in potassium?
  Discuss your diet with your healthcare provider. It is best to avoid high-potassium foods unless otherwise advised, especially if your blood potassium is high.
• What should I do if I miss a dose?
  Take it as soon as you remember. If it is nearly time for your next dose, skip the missed dose. Do not double up. Keep a regular routine to help you remember.
• Is Inspra safe in pregnancy or breastfeeding?
  Inspra is not recommended in pregnancy or while breastfeeding. Always discuss with your doctor if you are planning pregnancy or are pregnant.
• Are my repeat prescriptions for Inspra valid at all Australian pharmacies?
  Yes, your Inspra prescription is valid at any community or hospital pharmacy in Australia. Make sure you keep your repeats with you if travelling.